We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

54 hedge funds and large institutions have $10.5M invested in Abeona Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

4% more funds holding

Funds holding: 52 → 54 (+2)

0.23% less ownership

Funds ownership: 1.12% → 0.89% (-0.23%)

24% less capital invested

Capital invested by funds: $13.7M → $10.5M (-$3.22M)

50% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 16

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
16
Closed
8
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$1.07M
2
Renaissance Technologies
Renaissance Technologies
New York
+$40.7K
3
WVP
Worth Venture Partners
New Jersey
+$29.5K
4
HF
HRT Financial
New York
+$27.2K
5
Citigroup
Citigroup
New York
+$23.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$878K
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$799K
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$509K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$393K
5
JP Morgan Chase
JP Morgan Chase
New York
-$340K
Name Holding Trade Value Shares
Change 		Change in
Stake
CT
26
Cambridge Trust
Massachusetts
$21K – – –
CBFP
27
Cedar Brook Financial Partners
Ohio
$17K – – –
SC
28
Shay Capital
New York
$16K – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$14K – – –
SWP
30
Stratos Wealth Partners
Ohio
$13K +$11K +1,600 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$12K +$2.23K +324 +26%
MHS
32
M Holdings Securities
Oregon
$12K +$10.1K +1,472 New
UBS Group
33
UBS Group
Switzerland
$9K -$1.69K -246 -17%
TSS
34
Two Sigma Securities
New York
$9K +$7.44K +1,084 New
Jane Street
35
Jane Street
New York
$9K +$8.16K +1,188 New
EGM
36
Engineers Gate Manager
New York
$7K -$15.5K -2,251 -72%
WAM
37
Warberg Asset Management
Illinois
$7K -$240 -35 -4%
SW
38
SVB Wealth
Massachusetts
$6K – – –
HFM
39
Hartford Financial Management
Connecticut
$6K +$5.13K +747 New
WA
40
WealthTrust Axiom
Pennsylvania
$5K – – –
Victory Capital Management
41
Victory Capital Management
Texas
$4K -$426 -62 -8%
Squarepoint
42
Squarepoint
New York
$4K – – –
MML Investors Services
43
MML Investors Services
Massachusetts
$3K – – –
PA
44
Parallel Advisors
California
$3K +$2.75K +400 New
JP Morgan Chase
45
JP Morgan Chase
New York
$2K -$340K -49,572 -99%
MCC
46
Money Concepts Capital
Florida
$2K +$1.37K +200 New
TRCT
47
Tower Research Capital (TRC)
New York
$1K -$4.17K -607 -80%
Osaic Holdings
48
Osaic Holdings
Arizona
$1K – – –
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$38 -$509K -74,176 -100%
GCP
50
GSA Capital Partners
United Kingdom
– -$266K -31,523 Closed
1
2
3

ABEO Hedge Fund Activity: Q1 2022 in Review

54 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2022, worth a combined $10.5M — down 24% from $13.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ABEO positions and 8 closed out — a net gain of 2 holders — while 8 added to existing stakes and 16 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $1.07M. The largest seller was Morgan Stanley, cutting an estimated $878K.

  • 54 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2022, up from 52 in Q4 2021.
  • Funds reported $10.5M of Abeona Therapeutics stock for Q1 2022, down 24% quarter-over-quarter.
  • 10 funds opened new Abeona Therapeutics positions in Q1 2022 and 8 closed out, a net change of +2 holders.
  • The largest Abeona Therapeutics buyer in Q1 2022 was AIGH Capital Management, an estimated $1.07M added.
  • The largest Abeona Therapeutics seller in Q1 2022 was Morgan Stanley, an estimated $878K sold.

Based on aggregated 13F filings for Q1 2022.